Literature DB >> 33441709

Cerebral magnetic resonance imaging of coincidental infarction and small vessel disease in retinal artery occlusion.

Yong Dae Kim1,2, Jun Yup Kim3,4, Young Joo Park5, Sang Jun Park1, Sung Hyun Baik3, Jihoon Kang4, Cheolkyu Jung6, Se Joon Woo7.   

Abstract

There are several reports in the literature on the association between non-arteritic retinal artery occlusion (NA-RAO) and acute ischemic stroke. We investigated the burden of small vessel disease (SVD) and cerebral coincident infarction observed on cerebral magnetic resonance imaging (MRI) in patients with newly diagnosed NA-RAO. In this retrospective, observational, case-series study, consecutive patients with NA-RAO who underwent cerebral MRI within one month of diagnosis between September 2003 and October 2018 were included. The classification of NA-RAO was based on ophthalmologic and systemic examinations. We also investigated the co-incident infarction and burden of underlying SVD, which were categorized as white matter hyperintensity lesion (WMH), cerebral microbleeds (CMB), and silent lacunar infarction (SLI). Among the 272 patients enrolled in the study, 18% presented co-incident infarction and 73% had SVD, which included WMH (70%), CMB (14%), and SLI (30%). Co-incident infarction, WMH, and SLI significantly increased with age: co-incident infarction was observed in 8% of young (< 50 years) patients and 30% of old (≥ 70 years) patients. The embolic etiology of RAO (large artery atherosclerosis, cardioembolism, and undetermined etiology) was significantly associated with the prevalence of SVD (82%: 70%: 64%, P = 0.002) and co-incident infarction (30%: 19%: 8%; P = 0.009). Therefore, high co-incidence of acute cerebral infarction and underlying SVD burden warrant careful neurologic examination and appropriate brain imaging, followed by management of NA-RAO. Urgent brain imaging is particularly pertinent in elderly patients with NA-RAO.

Entities:  

Year:  2021        PMID: 33441709      PMCID: PMC7806736          DOI: 10.1038/s41598-020-80014-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  58 in total

1.  Urgent Evaluation of the Patient With Acute Central Retinal Artery Occlusion.

Authors:  Anthony C Arnold
Journal:  Am J Ophthalmol       Date:  2018-10-02       Impact factor: 5.258

2.  Risk and Risk Periods for Stroke and Acute Myocardial Infarction in Patients with Central Retinal Artery Occlusion.

Authors:  Sang Jun Park; Nam-Kyong Choi; Bo Ram Yang; Kyu Hyung Park; Joongyub Lee; Sun-Young Jung; Se Joon Woo
Journal:  Ophthalmology       Date:  2015-08-19       Impact factor: 12.079

3.  Microvascular network alterations in retina of subjects with cerebral small vessel disease.

Authors:  Saima Hilal; Yi-Ting Ong; Carol Y Cheung; Chuen Seng Tan; Narayanaswamy Venketasubramanian; Wiro J Niessen; Henri Vrooman; Ainur R Anuar; Merwyn Chew; Christopher Chen; Tien Yin Wong; Mohammad Kamran Ikram
Journal:  Neurosci Lett       Date:  2014-06-14       Impact factor: 3.046

4.  Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning.

Authors:  G L Moneta; J M Edwards; R W Chitwood; L M Taylor; R W Lee; C A Cummings; J M Porter
Journal:  J Vasc Surg       Date:  1993-01       Impact factor: 4.268

5.  Associations of retinal microvascular signs and intracranial large artery disease.

Authors:  Deidre A De Silva; Jennifer J F Manzano; Fung-Peng Woon; Erica Yang Liu; Moi-Pin Lee; Hui-Yee Gan; Christopher P L H Chen; Hui-Meng Chang; Paul Mitchell; Jie Jin Wang; Richard I Lindley; Tien-Yin Wong; Meng-Cheong Wong
Journal:  Stroke       Date:  2011-01-21       Impact factor: 7.914

Review 6.  Do Patients With Retinal Artery Occlusion Need Urgent Neurologic Evaluation?

Authors:  Sohan Singh Hayreh
Journal:  Am J Ophthalmol       Date:  2018-08-14       Impact factor: 5.258

7.  Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study.

Authors:  M Kamran Ikram; Frank Jan De Jong; Ewoud J Van Dijk; Niels D Prins; Albert Hofman; Monique M B Breteler; Paulus T V M De Jong
Journal:  Brain       Date:  2005-11-29       Impact factor: 13.501

8.  Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.

Authors:  Hyung-Min Kwon; Michael J Lynn; Tanya N Turan; Colin P Derdeyn; David Fiorella; Bethany F Lane; Jean Montgomery; L Scott Janis; Zoran Rumboldt; Marc I Chimowitz
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

Review 9.  Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions.

Authors:  Philip M Bath; Joanna M Wardlaw
Journal:  Int J Stroke       Date:  2015-03-02       Impact factor: 5.266

10.  Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysis.

Authors:  Sytze P Rensma; Thomas T van Sloten; Lenore J Launer; Coen D A Stehouwer
Journal:  Neurosci Biobehav Rev       Date:  2018-04-13       Impact factor: 8.989

View more
  2 in total

1.  Redefining the Koizumi model of mouse cerebral ischemia: A comparative longitudinal study of cerebral and retinal ischemia in the Koizumi and Longa middle cerebral artery occlusion models.

Authors:  Helena Justić; Anja Barić; Iva Šimunić; Marin Radmilović; Rok Ister; Siniša Škokić; Marina Dobrivojević Radmilović
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-24       Impact factor: 6.960

2.  Retinal Artery Occlusion and Its Impact on the Incidence of Stroke, Myocardial Infarction, and All-Cause Mortality during 12-Year Follow-Up.

Authors:  Joanna Roskal-Wałek; Paweł Wałek; Michał Biskup; Jacek Sidło; Elżbieta Cieśla; Dominik Odrobina; Jerzy Mackiewicz; Beata Wożakowska-Kapłon
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.